Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue.
EudraCT: 2008-004014-27
Phase 2 other completed
Quick answer
Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue. for Graft Versus Host Disease is a Phase 2 program (other) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lxo Ireland Designated Activity Company
- Indication
- Graft Versus Host Disease
- Phase
- Phase 2
- Modality
- other
- Status
- completed